Hints and tips:
...Speed was crucial, so Pfizer had to change how it worked....
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...The AU will pay $6.75 a dose for the BioNTech/Pfizer vaccine and $10 for Johnson & Johnson’s, a single-dose product....
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
...The group behind the Les Paul, Flying V and Epiphone brands filed for Chapter 11 bankruptcy protection in May, overwhelmed by the debt it took on to fund an ill-fated diversification into headphones and...
...Gillespie joined Gibson, Dunn in 2014 from Kirkland & Ellis. Before that, Gillespie was at Allen & Overy....
...(FT) Sour note Gibson guitar’s blue-chip financial backers and quirky roots are coming to a head in a potential bankruptcy....
...Selina Sagayam, a corporate finance specialist and head of practice development at law firm Gibson Dunn, says: “The regime has been effective in giving target boards breathing room while quickly pushing...
...Selina Sagayam, a partner at Gibson Dunn & Crutcher, says: “Procedural changes to the takeover code since Kraft and Cadbury have had the effect of increasing execution risks for bidders, but the impact has...
...The possibility of a Pfizer/AstraZeneca deal still has the politicians talking (the chief executives of both were hauled before the UK parliament this week)....
...beyondbrics India v China: a new race in biopharmaceuticals, beyondbrics...
...Pfizer, the largest US drugmaker by market value, inched down 0.7 per cent to $14.54 as the stock being removed from the “conviction buy” list at Goldman Sachs....
...Neil Gibson, chief scientific officer for Pfizer’s oncology research unit, said the project, which would cost several millions of dollars a year, should lead to initial publications within two years....
...Last week’s US jobs report has knocked investor confidence, and those predicting a V-shaped recovery are finding it harder to justify their positions....
...This spurred groups such as Pfizer of the US and Roche of Switzerland to strike multi-billion-dollar deals during the first half of this year....
...Kindler, Chairman and CEO, Pfizer Inc., USA Klaus Kleinfeld, President and CEO, Siemens AG, Germany Mustafa V....
...A number of the 400 diners were more moved by the World Cup, skipping dessert to go into Montreux to a bar to watch Ukraine v Switzerland, a match that yielded little poetry....
...He was born in 1954, the year, as he points out, of the famous Brown v Board of Education case which paved the way for US desegregation....
International Edition